BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1456 related articles for article (PubMed ID: 19299012)

  • 21. Formulation, characterization, and in vitro evaluation of quantum dots loaded in poly(lactide)-vitamin E TPGS nanoparticles for cellular and molecular imaging.
    Pan J; Wang Y; Feng SS
    Biotechnol Bioeng; 2008 Oct; 101(3):622-33. PubMed ID: 18727131
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multimodal tumor imaging by iron oxides and quantum dots formulated in poly (lactic acid)-D-alpha-tocopheryl polyethylene glycol 1000 succinate nanoparticles.
    Tan YF; Chandrasekharan P; Maity D; Yong CX; Chuang KH; Zhao Y; Wang S; Ding J; Feng SS
    Biomaterials; 2011 Apr; 32(11):2969-78. PubMed ID: 21257200
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cellular cytotoxicity and in-vivo biodistribution of docetaxel poly(lactide-co-glycolide) nanoparticles.
    Esmaeili F; Dinarvand R; Ghahremani MH; Ostad SN; Esmaily H; Atyabi F
    Anticancer Drugs; 2010 Jan; 21(1):43-52. PubMed ID: 19809300
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trastuzumab-functionalized nanoparticles of biodegradable copolymers for targeted delivery of docetaxel.
    Sun B; Feng SS
    Nanomedicine (Lond); 2009 Jun; 4(4):431-45. PubMed ID: 19505246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro and in vivo investigation on PLA-TPGS nanoparticles for controlled and sustained small molecule chemotherapy.
    Zhang Z; Lee SH; Gan CW; Feng SS
    Pharm Res; 2008 Aug; 25(8):1925-35. PubMed ID: 18509603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery.
    Chan JM; Zhang L; Yuet KP; Liao G; Rhee JW; Langer R; Farokhzad OC
    Biomaterials; 2009 Mar; 30(8):1627-34. PubMed ID: 19111339
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Robust aptamer-polydopamine-functionalized M-PLGA-TPGS nanoparticles for targeted delivery of docetaxel and enhanced cervical cancer therapy.
    Xu G; Yu X; Zhang J; Sheng Y; Liu G; Tao W; Mei L
    Int J Nanomedicine; 2016; 11():2953-65. PubMed ID: 27382282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of rhodamine loaded PEG-g-PLA nanoparticles (NPs): effect of poly(ethylene glycol) grafting density.
    Essa S; Rabanel JM; Hildgen P
    Int J Pharm; 2011 Jun; 411(1-2):178-87. PubMed ID: 21458551
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In-vitro evaluation of paclitaxel-loaded MPEG-PLGA nanoparticles on laryngeal cancer cells.
    Gao C; Pan J; Lu W; Zhang M; Zhou L; Tian J
    Anticancer Drugs; 2009 Oct; 20(9):807-14. PubMed ID: 19696655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nanoformulation of D-α-tocopheryl polyethylene glycol 1000 succinate-b-poly(ε-caprolactone-ran-glycolide) diblock copolymer for breast cancer therapy.
    Huang L; Chen H; Zheng Y; Song X; Liu R; Liu K; Zeng X; Mei L
    Integr Biol (Camb); 2011 Oct; 3(10):993-1002. PubMed ID: 21938302
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel powder formulations for controlled delivery of poorly soluble anticancer drug: application and investigation of TPGS and PEG in spray-dried particulate system.
    Mu L; Teo MM; Ning HZ; Tan CS; Feng SS
    J Control Release; 2005 Apr; 103(3):565-75. PubMed ID: 15820404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Practical preparation procedures for docetaxel-loaded nanoparticles using polylactic acid-co-glycolic acid.
    Keum CG; Noh YW; Baek JS; Lim JH; Hwang CJ; Na YG; Shin SC; Cho CW
    Int J Nanomedicine; 2011; 6():2225-34. PubMed ID: 22114486
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oleanolic acid-loaded PLGA-TPGS nanoparticles combined with heparin sodium-loaded PLGA-TPGS nanoparticles for enhancing chemotherapy to liver cancer.
    Gao M; Xu H; Bao X; Zhang C; Guan X; Liu H; Lv L; Deng S; Gao D; Wang C; Tian Y
    Life Sci; 2016 Nov; 165():63-74. PubMed ID: 27640889
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preparation and characterization of surface-modified PLGA-polymeric nanoparticles used to target treatment of intestinal cancer.
    Ahmad N; Alam MA; Ahmad R; Naqvi AA; Ahmad FJ
    Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):432-446. PubMed ID: 28503995
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro and in vivo evaluation of methoxy polyethylene glycol-polylactide (MPEG-PLA) nanoparticles for small-molecule drug chemotherapy.
    Dong Y; Feng SS
    Biomaterials; 2007 Oct; 28(28):4154-60. PubMed ID: 17576004
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS.
    Mu L; Feng SS
    J Control Release; 2003 Jan; 86(1):33-48. PubMed ID: 12490371
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ultrafine PEG-coated poly(lactic-co-glycolic acid) nanoparticles formulated by hydrophobic surfactant-assisted one-pot synthesis for biomedical applications.
    Chu CH; Wang YC; Huang HY; Wu LC; Yang CS
    Nanotechnology; 2011 May; 22(18):185601. PubMed ID: 21415469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting and imaging cancer cells by folate-decorated, quantum dots (QDs)- loaded nanoparticles of biodegradable polymers.
    Pan J; Feng SS
    Biomaterials; 2009 Feb; 30(6):1176-83. PubMed ID: 19062089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of polymer architecture on surface properties, plasma protein adsorption, and cellular interactions of pegylated nanoparticles.
    Sant S; Poulin S; Hildgen P
    J Biomed Mater Res A; 2008 Dec; 87(4):885-95. PubMed ID: 18228249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Co-delivery nanoparticles with characteristics of intracellular precision release drugs for overcoming multidrug resistance.
    Zhang D; Kong YY; Sun JH; Huo SJ; Zhou M; Gui YL; Mu X; Chen H; Yu SQ; Xu Q
    Int J Nanomedicine; 2017; 12():2081-2108. PubMed ID: 28356731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 73.